CBD regulation in France in 2026: what changes, what stays legal

What changes concerns only the CBD products that are ingested. Since 15 May 2026, the French authorities have been strictly applying Regulation (EU) 2015/2283, known as "Novel Food", to foodstuffs containing added CBD (Novel Food regulation). In practice, oils to be swallowed, capsules, gummies and sweets, infusions and herbal teas, drinks, chocolates and other edible foodstuffs may no longer be sold, for want of a European market authorisation. No grace period has been granted: the ban applies immediately to the products concerned.

The logic is legal before it is health-related. A "novel food" may only be marketed after an assessment and authorisation procedure at Union level. As long as CBD extracts intended for ingestion have not obtained that authorisation, they do not meet the condition for being placed on the market as a foodstuff. It is therefore not CBD as a molecule that is targeted, but its unauthorised food status.

Two broad families of products remain perfectly legal after 15 May 2026. First, raw CBD flowers and resins: in legal terms they are not considered foodstuffs and therefore fall outside the scope of the Novel Food regulation. Their marketing remains governed by the law applicable to hemp, but they do not fall under the ban on foods containing added CBD.

Second, CBD cosmetics clearly labelled for skin use — massage oils, balms, skincare. They come under a separate framework, Regulation (EC) 1223/2009 on cosmetic products (cosmetics regulation), which governs their composition, labelling and safety. As long as the product is presented for application to the skin and not for ingestion, it remains outside the scope of the ban. The decisive dividing line is therefore not the molecule but the declared use: you do not eat a cosmetic, and that is precisely what keeps it lawful.

CBD is not a narcotic, and that point has been settled at the highest European level. In its judgment of 19 November 2020 in the Kanavape case (C-663/18), the Court of Justice of the European Union held that cannabidiol does not constitute a narcotic and benefits from the principle of free movement of goods within the Union (CJEU, Kanavape). A member state may therefore not prohibit the marketing of CBD lawfully produced in another member state on the sole ground that it is cannabidiol.

This distinction is essential to understanding the situation in 2026. The ban affecting ingestible products does not rest on a reclassification of CBD as a narcotic — which would run counter to the Kanavape case law — but on food law. It is the status of an unauthorised "novel food" that blocks the sale of these foodstuffs, not a prohibition of the substance. The nuance may seem technical, but it explains why flowers and cosmetics escape the ban: they are simply not governed by the Novel Food regulation.

No. This is a frequent confusion that needs clearing up. Article 23 of the finance bill for 2026 provided for CBD flowers and extracts intended for smoking to be treated as tobacco, which would have meant applying an excise duty of about 25.7% plus €18 per kilogramme. That measure was withdrawn in January 2026. The "tobacco"-type tax was therefore not adopted and does not apply.

It is important not to confuse what was contemplated with what is in force. To date, no specific "tobacco" taxation weighs on CBD flowers as a result of that article. Flowers and resins keep their ordinary tax regime. This clarification matters all the more because the rumour of a "CBD tax" circulated widely: the regulatory reality of 2026 is that a tax measure was proposed and then abandoned, without ever entering positive law. For consumers, this means that the price of flowers has not been raised by a dedicated excise duty.

For an at-a-glance overview, here is the status of each broad product category as at 15 May 2026, together with the applicable legal framework. This table sums up the overall logic: the ban targets ingestion, not the molecule, and the legal framework changes according to the use made of the product.

How to read this table

The dividing line is simple: everything intended to be swallowed or drunk falls on the banned side, because CBD added to a foodstuff has no Novel Food authorisation. Everything that comes under another use — smoking a flower, applying a treatment to the skin — remains governed by a separate framework and stays legal in 2026.

Beyond legal status, the reliability of products remains a documented concern. A study conducted by MILDECA on 223 CBD products revealed significant discrepancies between label and actual content: 81% of products displayed a CBD content different from the one stated, of which 69% were below the indicated level (MILDECA, 2023). More worrying still, 6% of the products analysed contained undeclared psychoactive cannabinoids.

These figures are a reminder that the CBD market long suffered from a lack of control. For consumers, the lesson is concrete: favour products whose composition is verified and whose labelling is transparent. According to industry estimates, France has more than 2,000 specialist shops and around 16.4% of adults say they have already used CBD — a mass market that makes the demand for quality all the more warranted. By tightening the food offer, the 2026 regulatory framework shifts attention towards the categories that remain authorised, where traceability remains the best guide when buying.

Key points for your purchases in 2026

• Ingestible CBD products (oils to be swallowed, capsules, gummies, infusions, drinks, chocolates) are no longer on sale: they come under the Novel Food regulation, with no European authorisation.
• Raw flowers and resins remain legal: they are not foodstuffs.
• CBD cosmetics for skin use remain legal under Regulation (EC) 1223/2009.
• No "tobacco" tax applies to flowers: Article 23 of the 2026 Finance Bill was withdrawn in January 2026.
• Check the labelling and composition: discrepancies between label and actual content have been documented on a large scale.

Are all CBD oils banned?

Oils intended to be swallowed have been banned since 15 May 2026, because they constitute foodstuffs containing added CBD without Novel Food authorisation. By contrast, an oil clearly labelled and presented as a cosmetic for skin use (massage, skincare) comes under cosmetics regulation 1223/2009 and remains legal. The decisive criterion is the product's declared use, not its liquid form.

Can you still buy CBD flowers legally?

Yes. Raw CBD flowers and resins remain legal in France in 2026. In legal terms they are not considered foodstuffs and therefore do not fall within the scope of the Novel Food regulation that affects ingestible products. Nor are they treated as a narcotic, in line with the CJEU's Kanavape case law (CJEU).

Does a "tobacco" tax apply to CBD flowers?

No. Article 23 of the finance bill for 2026 provided for an excise duty of about 25.7% plus €18/kg by treating flowers intended for smoking as tobacco, but it was withdrawn in January 2026. That tax was never adopted and does not apply. CBD flowers keep their ordinary tax regime, with no specific surcharge linked to that article.

Is CBD considered a drug in France?

No. The Court of Justice of the European Union held in 2020, in the Kanavape case (C-663/18), that CBD is not a narcotic and benefits from the free movement of goods (CJEU). The 2026 ban does not reclassify CBD as a drug: it rests on food law, which blocks the sale of ingestible foodstuffs not authorised under the Novel Food regulation.

Why do CBD cosmetics remain authorised?

Because they come under a different legal framework. CBD cosmetics, presented for application to the skin, are governed by Regulation (EC) 1223/2009 on cosmetic products (cosmetics regulation), and not by food law. As they are not intended for ingestion, the Novel Food regulation does not apply. Their legality depends on clear labelling indicating skin use.

Should you be wary of the composition of CBD products?

Caution remains warranted. The MILDECA study of 223 products showed that 81% of them had a CBD content different from the label, and that 6% contained undeclared psychoactive cannabinoids (MILDECA, 2023). For a reliable purchase, favour products with verified composition and transparent labelling, in the categories that remain legal in 2026.

• European Parliament and Council. "Regulation (EU) 2015/2283 on novel foods (Novel Food)". *Official Journal of the European Union*, 2015
• European Parliament and Council. "Regulation (EC) 1223/2009 on cosmetic products". *Official Journal of the European Union*, 2009
• Court of Justice of the European Union. "Kanavape judgment, case C-663/18". *CJEU*, 2020
• MILDECA. "Study on the composition of 223 CBD products marketed in France". *Interministerial Mission for Combating Drugs and Addictive Behaviours*, 2023

At Phytogrammes, we focus our selection on the categories that remain legal and traceable: flowers, resins and CBD skincare with verified composition. CBD is not a medicine.